About This Page
This is a clinician-written, evidence-based guide aligned to the MCC Examination Objectives. It is structured by clinical presentation — the way the MCCQE tests and the way patients actually present. Management reflects current Canadian guidelines (CMA, CFPC, CPS). Always cross-reference with institutional protocols and clinical judgment.
The Bottom Line
- Third-trimester bleeding is an obstetric emergency: maternal stabilization takes priority over fetal assessment.
- Do not perform digital vaginal examination until placenta previa is excluded by ultrasound.
- Placenta previa classically causes painless bright red bleeding; abruption causes painful bleeding with uterine tenderness or hypertonus.
- Vasa previa causes bleeding with fetal bradycardia after membrane rupture — blood loss is fetal and can be rapidly fatal.
- Management depends on maternal stability, fetal status, gestational age, bleeding severity, and cause; severe bleeding or fetal compromise often requires urgent delivery.
Approach to the Presentation
Begin with ABCs, two large-bore IVs, maternal vitals, quantification of bleeding, fetal monitoring if viable, CBC/coagulation studies, blood group and crossmatch, and urgent obstetric involvement. A digital vaginal examination may precipitate catastrophic bleeding if placenta previa is present; speculum examination should be deliberate and safe.
Differential Diagnosis
| diagnosis | likelihood | key features | distinguishing test |
|---|---|---|---|
| Placental Abruption | must-not-miss | Painful vaginal bleeding, uterine tenderness, hypertonic uterus, contractions, fetal distress, hypertension, trauma, cocaine use; bleeding may be concealed. | Clinical diagnosis; ultrasound may miss abruption; CBC, fibrinogen/coagulation studies assess severity. |
| Placenta Previa | must-not-miss | Painless bright red bleeding, soft non-tender uterus, malpresentation, prior cesarean or uterine surgery, multiparity. | Transabdominal then transvaginal ultrasound to localize placenta; avoid digital examination. |
| Vasa Previa | must-not-miss | Bleeding after rupture of membranes with fetal bradycardia or sinusoidal tracing; risk factors include velamentous cord insertion, low-lying placenta, IVF, multiple pregnancy. | Prenatal transvaginal colour Doppler; acute diagnosis suggested by fetal distress with bleeding after membrane rupture. |
| Uterine Rupture | must-not-miss | Severe abdominal pain, abnormal fetal heart rate, loss of station, vaginal bleeding, maternal shock, prior uterine scar. | Clinical diagnosis requiring immediate laparotomy and delivery. |
| Preterm Labour / Cervical Change | common | Bleeding or show with regular contractions, pelvic pressure, cervical dilation or effacement, possible rupture of membranes. | Speculum/cervical assessment after previa excluded; fetal monitoring and ultrasound. |
| Cervical Ectropion or Polyp | common | Light bleeding or spotting, often postcoital or after examination; painless; cervix friable or polyp visible. | Speculum examination once safe; ultrasound excludes placental causes. |
| Cervicitis / Vaginitis | common | Spotting with discharge, odour, dyspareunia, dysuria, cervical friability. | Speculum examination, NAAT for chlamydia/gonorrhoea, wet mount or swabs. |
| Lower Genital Tract Trauma | less common | Bleeding after intercourse, fall, intimate partner violence, or instrumentation. | Careful speculum examination after obstetric causes considered; assess safety and safeguarding. |
| Bloody Show at Term | less common | Mucus mixed with small amount of blood near onset of labour; mild contractions; no compromise. | Diagnosis of exclusion after assessing bleeding amount, placental location, and fetal status. |
| Placenta Accreta Spectrum | rare | Bleeding in patient with placenta previa and prior cesarean; high risk of massive haemorrhage at delivery. | Ultrasound/MRI antenatal suspicion; definitive diagnosis often at delivery. |
Red Flags & Key History
Symptoms
Haemodynamic instability, syncope, severe pain, fever, or altered mental status — urgent assessment required.
Pregnancy possibility, positive pregnancy test, or pregnancy-related symptoms must change the diagnostic pathway.
Persistent, recurrent, or unexplained symptoms despite initial management require reassessment.
Cancer red flags such as postcoital/postmenopausal bleeding, mass, weight loss, or persistent abnormal discharge require diagnostic evaluation.
Patient priorities, fertility goals, contraception needs, trauma history, and psychosocial impact are central to management.
Medication, device, postpartum, lactation, and STI risk history often explains the presentation.
Signs
Abnormal vital signs, shock, sepsis, peritonism, hypoxia, severe hypertension, or neurological features.
Mass, cervical lesion, adnexal tenderness/mass, uterine tenderness, or abnormal bleeding on examination.
Fever, purulent discharge, cervical motion tenderness, wound infection, or breast erythema/fluctuance when relevant.
Normal examination does not exclude early pregnancy complications, endometriosis, intermittent torsion, or paroxysmal symptoms.
Document chaperone use, consent, and patient comfort for intimate examinations.
Approach to Investigation
First-line
Pregnancy test when pregnancy is possibleMandatory for reproductive-age presentations where bleeding, pain, amenorrhea, contraception failure, or procedure planning is relevant.
Focused history and examinationUse a trauma-informed approach; perform pelvic, breast, abdominal, or postpartum examination only when clinically indicated and consented.
CBC and targeted basic labsAssess anaemia, infection, platelets, renal/liver involvement, or endocrine clues depending on presentation.
Targeted microbiology or imagingUse STI NAAT, urinalysis, transvaginal ultrasound, breast imaging, fetal monitoring, or cervical testing according to the presentation.
Second-line
Ultrasound or diagnostic imagingPelvic, obstetric, breast, renal, or abdominal imaging according to the suspected diagnosis and pregnancy status.
Endocrine or tumour-directed testingUse TSH, prolactin, FSH/estradiol, androgen testing, CA-125, or biopsy only when the clinical pattern supports it.
Tissue diagnosis or samplingEndometrial biopsy, cervical biopsy/colposcopy, breast core biopsy, or hysteroscopy when malignancy, hyperplasia, or discordant findings are suspected.
Specialist
Gynecology/obstetric referralFor emergency, pregnancy-related, surgical, malignant, refractory, fertility-related, or complex presentations.
Multidisciplinary referralUse fertility, oncology, breast clinic, psychiatry, endocrinology, urology, pediatrics/neonatal, or social supports when indicated.
Management Principles
SOGC / Canadian specialty guidance + MCCQE1 clinical presentation approach1
Stabilize and exclude emergencies
- Assess ABCs, vital signs, pregnancy status, bleeding severity, sepsis, severe pain, severe hypertension, fetal status, and psychiatric safety as relevant.
- Call obstetrics/gynecology, anesthesia, blood bank, neonatal, psychiatry, surgery, or oncology early when red flags exist.
- Provide analgesia, antiemetics, fluids, antibiotics, antihypertensives, magnesium sulphate, or blood products when clinically indicated.
2
Treat according to most likely cause
- Use Canadian/SOGC/PHAC/Cancer Care Ontario-aligned pathways rather than non-Canadian defaults.
- Match management to patient goals: fertility, contraception, pregnancy continuation, breastfeeding, sexual function, symptom relief, and cancer risk.
- Do not delay empiric treatment for PID, obstetric emergency management, sepsis care, or psychiatric safety planning while waiting for confirmatory tests.
3
Shared decision-making and follow-up
- Explain uncertainty, expected course, treatment options, and return precautions in plain language.
- Arrange reliable follow-up for serial beta-hCG, repeat imaging, biopsy results, colposcopy, mental health review, or specialist assessment.
- Address equity, confidentiality, trauma history, intimate partner violence, cost, geography, and access barriers.
Complications & Pitfalls
- Skipping pregnancy testing: Many reproductive presentations change completely when pregnancy is present.
- Premature closure: Do not label symptoms as benign until must-not-miss causes have been considered.
- Ignoring red flags: Haemodynamic instability, sepsis, severe pain, psychosis, severe hypertension, or suspicious bleeding/mass require escalation.
- Overusing low-value care: Testing should be targeted; Pap tests, imaging, or hormone panels are not always required.
- Under-communicating follow-up: Serial testing, biopsy results, and safety-netting must be explicit.
MCCQE1 Exam Tips
- 1MCCQE1 reproductive questions are presentation-based: start with stability, pregnancy status, and must-not-miss diagnoses.
- 2The next best step is often the safest first step: beta-hCG, vital signs, focused examination, ultrasound, or urgent consultation depending on the vignette.
- 3Do not perform unsafe examinations or procedures before excluding key contraindications, such as digital vaginal examination before placenta previa is excluded.
- 4Canadian practice matters: use SOGC, PHAC STI guidance, Cancer Care Ontario pathways, and Choosing Wisely Canada principles where relevant.
- 5CanMEDS communicator role is common: consent, confidentiality, trauma-informed examination, shared decision-making, and sensitive counselling are testable.
- 6CanMEDS collaborator role is central in obstetric emergencies and cancer pathways: involve the right team early.
- 7Safety-netting is part of management: worsening pain, fever, heavy bleeding, syncope, fetal concerns, psychosis, or delayed follow-up require urgent reassessment.
practicetest your knowledge on vaginal bleeding — pregnant (third trimester / antepartum haemorrhage)Apply what you've learnt with MCCQE1-style questions from the iatroX Q-Bank — reproductive & obstetric and beyond.
open q-bank